News | July 01, 2007

Hologic Introduces Suros "Second Shape" Biopsy Markers to Identify Multiple Biopsy Sites in the Same Breast

July 2, 2007 - Hologic Inc. recently announced that it has introduced for the U.S. breast biopsy market two new second shape titanium breast biopsy markers, TriMark 2S and CeleroMark 2S, containing a unique “hourglass” shape to help clinicians mark and independently identify multiple biopsy sites in the same breast.

The current Suros family of markers includes the ATEC TriMark and Suros CeleroMark biopsy site identifiers. These markers are compatible with the ATEC breast biopsy and excision system and Suros Celero ultrasound biopsy device, respectively. The standard TriMark identifier is a cylinder-shaped titanium pellet. The new 2S markers are half the size of the standard TriMark and can be used in conjunction with the current family of Suros biopsy site identifiers.

At least 70 percent of all breast biopsies require site identifiers with more than 800,000 used every year in the U.S. Single breast, multiple lesion biopsies are performed at different percentage rates depending on the imaging modality used in the biopsy. It is estimated that in a single breast, multiple biopsies are performed 10 percent of the time using ultrasound guidance, 5 percent in stereotactic X-ray and 40 percent with MRI-guided breast biopsy.

For more information: www.hologic.com

Related Content

Hologic, ECR 2017, breast cancer screening solutions, Affirm prone biopsy system

The Affirm prone biopsy system. Image courtesy of Hologic.

News | Breast Imaging | March 14, 2017
Hologic Inc. highlighted its portfolio of innovative breast cancer screening and interventional products, including new...
Sponsored Content | Videos | Women's Health | November 16, 2016
The purpose of this exploratory video roundtable is to examine the state of breast biopsies today and to communicate...
stereotactic breast imaging

This image shows a 52-year-old patient with benign calcifications in her pre-stereotactic breast biopsy screening.

Feature | Breast Biopsy Systems | November 01, 2016 | By Laura Shepardson, M.D.
Recently, I was invited to participate in a...
Hologic, FDA approval, launch, Affirm prone biopsy system, breast cancer, women's health
Technology | Breast Biopsy Systems | April 21, 2016
Hologic Inc. announced the U.S. Food and Drug Administration (FDA) clearance and commercial launch of the Affirm prone...

Breast surgeon Michael Cross, M.D., has done clinical research on the DotMed BioZorb surgical marker. (Photo courtesy of DotMed)

Feature | Women's Health | November 11, 2015
Breast cancer research conducted by two Fayetteville, Ark., medical groups highlights their success in pioneering use
Hologic, RSNA 2015, breast tomosynthesis, breast biopsy systems

I-View contrast enhanced 2-D mammography image courtesy of Hologic

Technology | Breast Imaging | October 02, 2015
October 2, 2015 — At the Radiological Society of North America’s (RSNA) 2015 annual meeting, Hologic will emphasize i
hologic mammography Selin
News | Breast Imaging | October 01, 2015
October 1, 2015 — The recent KLAS Research women’s imaging report, Women's Imaging 2015.
Cianna Medical, SAVI Scout, breast surgical guidance system

Photo courtesy of Cianna Medical

Technology | December 16, 2014
Cianna Medical Inc. received U.S. Food and Drug Administration (FDA) clearance for the SAVI Scout surgical guidance...
News | November 12, 2014
GTCR, a private equity firm, announced Devicor Medical Products has signed an agreement to be acquired by Danaher Corp...
News | November 11, 2014
Seno Medical Instruments Inc. announced that the use of the Seno Imagio breast imaging system and the associated...
Overlay Init